anvil 400 400 mg soft gelatin capsule
atc health care international corp.; distributor: atc health care international corp. - ibuprofen - soft gelatin capsule - 400 mg
rivastigmine 3m health care ltd
3m health care limited - rivastigmine - alzheimer disease - psychoanaleptics, , anticholinesterases - symptomatic treatment of mild to moderately severe alzheimer's dementia.
evorel sequi
j-c health care ltd - estradiol as hemihydrate; estradiol as hemihydrate; norethisterone acetate - patches - estradiol as hemihydrate 3.2 mg; norethisterone acetate 11.2 mg; estradiol as hemihydrate 3.2 mg - estradiol, combinations - estradiol, combinations - hormone replacement therapy for the relief of menopausal symptoms.
evra transdermal patch (6 mg600 mcg)
abbott laboratories (singapore ) private limited - ethinylestradiol; norelgestromin - patch - 600 mcg/patch - ethinylestradiol 600 mcg/patch; norelgestromin 6 mg/patch
cooling patch
julphar drug store l.l.c china - 5 patches [6x12 cm (12000007)] - patch - patch - skin-n/a
thermo relax back shoulder pain multifunction self-heating patch
alain medical store italy - 3’s [3x1’s self heating patches] - patch - patch - medical devices-medical devices
thermo relax back shoulder pain multifunction self-heating patch
al ain medical store sole proprietorship llc italy - 3’s [3x1’s self heating patches] - patch - patch - medical devices-medical devices
fenpatch 100 fentanyl 100 mcg/hr transdermal patch pouch
medis pharma pty ltd - fentanyl, quantity: 16.5 mg - drug delivery system, transdermal - excipient ingredients: titanium dioxide; polypropylene; polyethylene terephthalate; ethyl acetate; 2-ethylhexyl acrylate/2-hydroxyethyl acrylate/methyl acrylate copolymer; hexane - for the management of pain associated with cancer, palliative care, and other conditions in patients where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? severe enough to require daily, continuous, long term opioid treatment. not for use in opioid-na?ve patients.
fenpatch 75 fentanyl 75 mcg/hr transdermal patch pouch
medis pharma pty ltd - fentanyl, quantity: 12.375 mg - drug delivery system, transdermal - excipient ingredients: polypropylene; polyethylene terephthalate; titanium dioxide; ethyl acetate; 2-ethylhexyl acrylate/2-hydroxyethyl acrylate/methyl acrylate copolymer; hexane - for the management of pain associated with cancer, palliative care, and other conditions in patients where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? severe enough to require daily, continuous, long term opioid treatment. not for use in opioid-na?ve patients.
fenpatch 50 fentanyl 50 mcg/hr transdermal patch pouch
medis pharma pty ltd - fentanyl, quantity: 8.25 mg - drug delivery system, transdermal - excipient ingredients: titanium dioxide; polypropylene; polyethylene terephthalate; ethyl acetate; 2-ethylhexyl acrylate/2-hydroxyethyl acrylate/methyl acrylate copolymer; hexane - for the management of pain associated with cancer, palliative care, and other conditions in patients where: ? other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and ? the pain is opioid-responsive, and ? severe enough to require daily, continuous, long term opioid treatment. not for use in opioid-na?ve patients.